Medivie Therapeutic Ltd (MDVI) - Total Assets
Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) holds total assets worth ILA4.67 Million ILA (≈ $12.53K USD) as of June 2021. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MDVI net asset value for net asset value and shareholders' equity analysis.
Medivie Therapeutic Ltd - Total Assets Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd's total assets have evolved over time, based on quarterly financial data.
Medivie Therapeutic Ltd - Asset Composition Analysis
Current Asset Composition (December 2020)
Medivie Therapeutic Ltd's total assets of ILA4.67 Million consist of 41.6% current assets and 58.5% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 34.0% |
| Accounts Receivable | ILA759.00K | 6.2% |
| Inventory | ILA101.00K | 0.8% |
| Property, Plant & Equipment | ILA5.77 Million | 47.3% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Medivie Therapeutic Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medivie Therapeutic Ltd's current assets represent 41.6% of total assets in 2020, a decrease from 76.0% in 2010.
- Cash Position: Cash and equivalents constituted 34.0% of total assets in 2020, down from 46.6% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2010.
- Asset Diversification: The largest asset category is property, plant & equipment at 47.3% of total assets.
Medivie Therapeutic Ltd Competitors by Total Assets
Key competitors of Medivie Therapeutic Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
LOT VACUUM Co. Ltd
KQ:083310
|
Korea | ₩320.63 Billion |
|
Komelon Corporation
KQ:049430
|
Korea | ₩255.94 Billion |
|
HS Valve Co. Ltd
KQ:039610
|
Korea | ₩133.14 Billion |
|
SPG Co. Ltd
KQ:058610
|
Korea | ₩424.42 Billion |
|
BHI Co. Ltd
KQ:083650
|
Korea | ₩786.24 Billion |
|
Woori Technology Inc
KQ:032820
|
Korea | ₩332.19 Billion |
|
VITZROCELL Co.Ltd
KQ:082920
|
Korea | ₩348.03 Billion |
|
Tae Kwang Corporation
KQ:023160
|
Korea | ₩724.75 Billion |
Medivie Therapeutic Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.36 | 0.92 | 2.21 |
| Quick Ratio | 0.36 | 0.90 | 2.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-5.64 Million | ILA-564.00K | ILA1.16 Million |
Medivie Therapeutic Ltd - Advanced Valuation Insights
This section examines the relationship between Medivie Therapeutic Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.59 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -9.6% |
| Total Assets | ILA12.19 Million |
| Market Capitalization | $516.77K USD |
Valuation Analysis
Below Book Valuation: The market values Medivie Therapeutic Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Medivie Therapeutic Ltd's assets decreased by 9.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Medivie Therapeutic Ltd (2010–2020)
The table below shows the annual total assets of Medivie Therapeutic Ltd from 2010 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | ILA12.19 Million ≈ $32.69K |
-9.62% |
| 2019-12-31 | ILA13.49 Million ≈ $36.17K |
-18.23% |
| 2018-12-31 | ILA16.50 Million ≈ $44.23K |
-16.30% |
| 2017-12-31 | ILA19.71 Million ≈ $52.85K |
+727.54% |
| 2016-12-31 | ILA2.38 Million ≈ $6.39K |
+312.11% |
| 2015-12-31 | ILA578.00K ≈ $1.55K |
-85.48% |
| 2014-12-31 | ILA3.98 Million ≈ $10.67K |
+655.22% |
| 2013-12-31 | ILA527.00K ≈ $1.41K |
-80.32% |
| 2012-12-31 | ILA2.68 Million ≈ $7.18K |
-79.58% |
| 2011-12-31 | ILA13.12 Million ≈ $35.16K |
+239.59% |
| 2010-12-31 | ILA3.86 Million ≈ $10.35K |
-- |
About Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more